Sanofi, Access Industries and Alphabet helped Areteia Therapeutics raise $350m, and Nordisk Games acquires Supermassive Games.

Funding US-based asthma therapy developer Areteia Therapeutics has raised $350m from investors including pharmaceutical firm Sanofi, internet and technology group Alphabet’s GV subsidiary and Access Biotechnology, part of conglomerate Access Industries. The round was led by private equity firm Bain Capital through its Bain Capital Life Sciences fund, while Arch Venture Partners, Saturn Partners, Maverick…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.